Response to: 'Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care' by Parperis et al
- PMID: 31801739
- DOI: 10.1136/annrheumdis-2019-216671
Response to: 'Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care' by Parperis et al
Keywords: NSAIDs; gout; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care.Ann Rheum Dis. 2020 Feb;79(2):276-284. doi: 10.1136/annrheumdis-2019-216154. Epub 2019 Oct 30. Ann Rheum Dis. 2020. PMID: 31666237 Free PMC article. Clinical Trial.
-
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care.Ann Rheum Dis. 2021 Dec;80(12):e202. doi: 10.1136/annrheumdis-2019-216643. Epub 2019 Nov 27. Ann Rheum Dis. 2021. PMID: 31776116 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical